Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Classical hematology 1

Conditions

Venous Thromboembolism 2Thrombosis 2Hemorrhage 2Venous Thrombosis 1Thromboembolism 1Thrombocytopenia 1Sarcoma 1Pulmonary Embolism 1Pancreatic Neoplasms 1Liver Neoplasms 1Hematoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Bone Neoplasms 1

Interventions

Enoxaparin 2apixaban 1Heparin, Low-Molecular-Weight 1Arginine Vasopressin 1Arginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Thrombosis × Enoxaparin × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

NCT05245877 2025-02-14

PREPOSTEROUS2

Helsinki University Central Hospital

Phase 4 Recruiting
800 enrolled
Gastrointestinal

Hemorrhage, Pancreatic Neoplasms, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡